Cargando…
Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series
The coronavirus disease 2019 (COVID-19) pandemic remains one of the largest global health crises of the last century. Fortunately, COVID-19 vaccines have proven to be one of the most promising options in halting the progression of the pandemic. As more and more people receive COVID-19 vaccines, the...
Autores principales: | Bekal, Sundeep, Husari, George, Okura, Marcel, Huang, Charity A, Bukari, Mohammed S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400017/ https://www.ncbi.nlm.nih.gov/pubmed/37546104 http://dx.doi.org/10.7759/cureus.41371 |
Ejemplares similares
-
Comparative Analysis of De Novo Immune Thrombocytopenia Following mRNA COVID-19 Vaccine Versus Non-mRNA Vaccines and COVID-19: A Global Database Analysis
por: Mericliler, Meric
Publicado: (2023) -
Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2023) -
CMV Infection Following mRNA SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
por: Chakravorty, Shourjo, et al.
Publicado: (2022) -
Comparable mRNA expression of inflammatory markers but lower claudin-1 mRNA levels in foreskin tissue of HSV-2 seropositive versus seronegative asymptomatic Kenyan young men
por: Röhl, Maria, et al.
Publicado: (2015) -
Unilateral parotitis following mRNA coronavirus disease 2019 vaccination
por: Bekci, Tumay, et al.
Publicado: (2022)